{"id":6758,"date":"2020-09-17T18:42:37","date_gmt":"2020-09-17T18:42:37","guid":{"rendered":"https:\/\/househearing.fm1.dev\/?p=6758"},"modified":"2023-05-17T08:31:36","modified_gmt":"2023-05-17T15:31:36","slug":"hearing-loss-may-increase-cognitive-defects-in-children-who-survive-cancer","status":"publish","type":"post","link":"https:\/\/househearing.com\/hearing-loss-may-increase-cognitive-defects-in-children-who-survive-cancer\/","title":{"rendered":"Hearing Loss May Increase Cognitive Defects in Children Who Survive Cancer"},"content":{"rendered":"\n

Recent research by a team a St. Jude Children\u2019s Research Hospital has found that childhood cancer survivors who have severe hearing impairment caused by their treatments are at greater risk for neurocognitive deficits. This is true even for children who did not undergo neurotoxic treatment.<\/p>\n\n\n

What Is Ototoxicity?<\/h2>\n\n
\n
\"Children<\/figure><\/div>\n\n\n

Certain chemicals and medications are known to cause damage to the cochlea and auditory nerve; these are considered ototoxic. There are over 200 known ototoxic medications<\/a> on the market today, and many are used to treat serious illnesses.<\/p>\n\n\n\n

While many drugs for treating cancer are known to cause hearing and balance issues, the benefits outweigh the risk of damage to the auditory system.<\/p>\n\n\n

About the Study<\/h2>\n\n\n

Researchers analyzed data from over 1,500 children who survived childhood cancer and who are a part of the St. Jude Lifetime Cohort Study. Data was collected between 2007 and 2017 and included both audiologic and neurocognitive testing.<\/p>\n\n\n\n

Of the 1,520 children who took part in the study\u2026<\/p>\n\n\n\n